Status:
NOT_YET_RECRUITING
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
Lead Sponsor:
University of Oklahoma
Conditions:
Prostate Cancer
Eligibility:
MALE
18-100 years
Brief Summary
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different ge...
Detailed Description
This study aims to establish a comprehensive database of Native American (NA) patients diagnosed with prostate cancer (PC), focusing on an in-depth characterization of the genomic landscape. Archived ...
Eligibility Criteria
Inclusion
- Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
- At least 18 years-of-age at the time of signature of the informed consent form (ICF).
- Patients who self-identify as Native American.
- Patients with a pathologically proven diagnosis of PC (any stage).
- Availability of most recent archived tumor samples.
Exclusion
- Patients not of Native American descent or identity.
- Patient does not have archival tissue available.
Key Trial Info
Start Date :
May 2 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2029
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06960798
Start Date
May 2 2026
End Date
June 30 2029
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States, 73117